Lonza Group Equity 2024

Lonza Group Equity

9.45 B CHF

Lonza Group Dividend yield

0.34 %

Ticker

LONN.SW

ISIN

CH0013841017

WKN

928619

In 2024, Lonza Group's equity was 9.45 B CHF, a -10.8% increase from the 10.6 B CHF equity in the previous year.

Lonza Group Aktienanalyse

What does Lonza Group do?

The Lonza Group AG is a global company based in Basel, Switzerland. It was founded in 1897 and has since had a long history of operational excellence and innovation. Lonza is a leading provider of customized chemical and biotechnological solutions and services for customers in the health, agrochemical, life science, and other sectors. Lonza's business model is based on providing customized, customer-oriented solutions for complex chemical and biological challenges. The company focuses on three main divisions: Pharma & Biotech, Consumer Health, and Specialty Ingredients. Within these divisions, Lonza offers a variety of products, services, and solutions tailored to meet the specific needs of its customers. In the Pharma & Biotech division, Lonza offers a wide range of products and services for the pharmaceutical and biotechnology industries. The company is a global leader in active ingredients for the pharmaceutical industry and also provides custom process development and manufacturing services for biopharmaceuticals and small molecules. In the Consumer Health division, Lonza develops and produces a variety of dietary supplements, cosmetic products, and household products for its customers. The company is a recognized expert in the formulation and production of high-quality dietary supplements and has also established a strong position in the production of natural cosmetic products in recent years. Lonza's Specialty Ingredients division offers a wide range of chemical and biotechnological products and services for the life science and specialty chemical industries. This includes products and services such as microbial control, material protection, custom development services, and others. Lonza is a leading manufacturer and supplier of dietary supplements, pharmaceutical active ingredients, agrochemicals, cosmetic ingredients, and other chemical and biotechnological products. The company has extensive expertise in process development and optimization, as well as in the manufacturing of products for various industries. One of Lonza's key products is the active ingredient Mipomersen, which is used in the treatment of familial hypercholesterolemia. Lonza is also a major provider of dietary supplements, particularly vitamins, minerals, omega-3 fatty acids, and other nutrients that can promote and support human health. Another important product of Lonza is the biosimilar component recombinant human insulin, which is used in the treatment of diabetes. Overall, Lonza is an innovative and leading company in the field of chemistry and biotechnology. With a strong focus on customer-oriented solutions and a broad portfolio of products and services, the company is well positioned to meet the growing demand for chemical and biological solutions in various industries. Lonza Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Lonza Group's Equity

Lonza Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Lonza Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Lonza Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Lonza Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Lonza Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Lonza Group Stock

What is the equity of Lonza Group this year?

Lonza Group has equity of 9.45 B CHF this year.

What was the equity of Lonza Group compared to the previous year?

The equity of Lonza Group has increased/decreased by -10.8% decreased compared to the previous year.

What impact does a high equity have on investors of Lonza Group?

A high equity is advantageous for investors of Lonza Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Lonza Group?

A low equity can be a risk for investors of Lonza Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Lonza Group affect the company?

An increase in equity of Lonza Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Lonza Group affect the company?

A reduction in equity of Lonza Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Lonza Group?

Some factors that can affect the equity of Lonza Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Lonza Group so important for investors?

The equity of Lonza Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Lonza Group take to change the equity?

To change equity, Lonza Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Lonza Group pay?

Over the past 12 months, Lonza Group paid a dividend of 1.75 CHF . This corresponds to a dividend yield of about 0.34 %. For the coming 12 months, Lonza Group is expected to pay a dividend of 1.93 CHF.

What is the dividend yield of Lonza Group?

The current dividend yield of Lonza Group is 0.34 %.

When does Lonza Group pay dividends?

Lonza Group pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Lonza Group?

Lonza Group paid dividends every year for the past 0 years.

What is the dividend of Lonza Group?

For the upcoming 12 months, dividends amounting to 1.93 CHF are expected. This corresponds to a dividend yield of 0.38 %.

In which sector is Lonza Group located?

Lonza Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lonza Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lonza Group from 5/15/2024 amounting to 2 CHF, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.

When did Lonza Group pay the last dividend?

The last dividend was paid out on 5/15/2024.

What was the dividend of Lonza Group in the year 2023?

In the year 2023, Lonza Group distributed 1.5 CHF as dividends.

In which currency does Lonza Group pay out the dividend?

The dividends of Lonza Group are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lonza Group

Our stock analysis for Lonza Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lonza Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.